このエピソードについて
Join Leone Atkinson, Fortrea’s Executive Medical Director of Neuroscience and Ophthalmology, and Dr. John Huffaker from the Neuropsychiatric Research Center as they discuss the evolving landscape of Alzheimer’s clinical trials. Explore challenges in patient recruitment and retention, the role of caregivers, and how digital tools and AI are transforming at-home data collection. Learn why collaboration between CROs, sponsors, and research sites is key to advancing patient-centric trial design and improving outcomes.
英語
アメリカ合衆国
文字起こし 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
このポッドキャストの他のエピソード
Host: Amber Burg, Therapeutic Delivery Head of Neuroscience and Ophthalmology at Fortrea
Participants:
Leone Atkinson, Executive Medical Director of Neuroscience and Ophthalmology, Fortrea
Robin Wolz, Chief Scientific Officer at Ixico
Description: This episode features an insightful interview bet…
Host: Amber Burg, Therapeutic Delivery Head of Neuroscience and Ophthalmology at Fortrea
Participants:
Abby Fuller, Senior Director of Strategic Delivery Growth in Neuroscience, Fortrea
Walter Gonzalez, Associate Director, Digital Health and Innovation, Fortrea
Haiyan Wei, SVP of Technology and O…
Host: Amber Burg, Therapeutic Delivery Head of Neuroscience and Ophthalmology at Fortrea
Participants:
Leone Atkinson, Executive Medical Director of Neuroscience and Ophthalmology at Fortrea
Alicia Baker, Vice President, Head of Global Regulatory Strategy at Fortrea
Description: Digital endpoints …
Host: Amber Burg, Therapeutic Delivery Head of Neuroscience and Ophthalmology at Fortrea
Participants:
Joanie Brown, Head of Operations at our Rapid Development Studio AI/ML, Fortrea
Mark Austin, Chief Technology Officer at Ixico
Description: In this episode of the Fortrea neuroscience podcast, w…
免責: このページに埋め込まれているポッドキャストとアートワークは Fortrea からのものであり、その所有者の所有物であり、Listen Notes, Inc. と提携または承認されていません。
